{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:36:22Z","timestamp":1772663782078,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82030037"],"award-info":[{"award-number":["82030037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82301423"],"award-info":[{"award-number":["82301423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z221100007422016"],"award-info":[{"award-number":["Z221100007422016"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12035-025-04700-3","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T16:08:57Z","timestamp":1738339737000},"page":"7380-7392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combining Single-Cell RNA Sequencing and Mendelian Randomization to Explore Novel Drug Targets for Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Xiaolong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"4700_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-022-00282-2","volume":"8","author":"R Dhanwani","year":"2022","unstructured":"Dhanwani R, Lima-Junior JR, Sethi A, Pham J, Williams G, Frazier A et al (2022) Transcriptional analysis of peripheral memory T cells reveals Parkinson\u2019s disease-specific gene signatures. NPJ Parkinsons Dis 8:30","journal-title":"NPJ Parkinsons Dis"},{"key":"4700_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:73","journal-title":"Signal Transduct Target Ther"},{"key":"4700_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670\u20131683","journal-title":"JAMA"},{"key":"4700_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"4700_CR5","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, Duan D, Yu D, Nong H et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:776847","journal-title":"Front Public Health"},{"key":"4700_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.08.002","volume":"169","author":"Z Chen","year":"2018","unstructured":"Chen Z, Chen S, Liu J (2018) The role of T cells in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 169:1\u201323","journal-title":"Prog Neurobiol"},{"key":"4700_CR7","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","volume":"269","author":"Y He","year":"2022","unstructured":"He Y, Peng K, Li R, Zhang Z, Pan L, Zhang T et al (2022) Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson\u2019s disease. J Neurol 269:5368\u20135381","journal-title":"J Neurol"},{"issue":"625\u2013640","key":"4700_CR8","first-page":"e624","volume":"182","author":"E Pasciuto","year":"2020","unstructured":"Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD, Theys T et al (2020) Microglia require CD4 T cells to complete the fetal-to-adult transition. Cell 182(625\u2013640):e624","journal-title":"Cell"},{"key":"4700_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.parkreldis.2018.10.029","volume":"60","author":"JK Baird","year":"2019","unstructured":"Baird JK, Bourdette D, Meshul CK, Quinn JF (2019) The key role of T cells in Parkinson\u2019s disease pathogenesis and therapy. Parkinsonism Relat Disord 60:25\u201331","journal-title":"Parkinsonism Relat Disord"},{"key":"4700_CR10","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192","journal-title":"J Clin Invest"},{"key":"4700_CR11","doi-asserted-by":"publisher","first-page":"10216","DOI":"10.1007\/s12035-024-04197-2","volume":"61","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shi X, Yin Y, Yang F, Zhang Y, He X et al (2024) Association between neuroinflammation and Parkinson\u2019s disease: a comprehensive mendelian randomization study. Mol Neurobiol. 61:10216\u201310226","journal-title":"Mol Neurobiol."},{"key":"4700_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19","journal-title":"Transl Neurodegener"},{"key":"4700_CR13","doi-asserted-by":"publisher","first-page":"1340110","DOI":"10.3389\/fnagi.2024.1340110","volume":"16","author":"Z Song","year":"2024","unstructured":"Song Z, Li W, Han Y, Xu Y, Ding H, Wang Y (2024) Association of immune cell traits with Parkinson\u2019s disease: a Mendelian randomization study. Front Aging Neurosci 16:1340110","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"4700_CR14","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3390\/ijms23084148","volume":"23","author":"TW Liu","year":"2022","unstructured":"Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 23(8):4148","journal-title":"Int J Mol Sci"},{"key":"4700_CR15","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, International Parkinson\u2019s Disease Genomics C et al (2021) Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat Commun. 12:7342","journal-title":"Nat Commun."},{"key":"4700_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA 323:844\u2013853","journal-title":"JAMA"},{"key":"4700_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.12688\/f1000research.10100.1","volume":"6","author":"WH Oertel","year":"2017","unstructured":"Oertel WH (2017) Recent advances in treating Parkinson\u2019s disease. F1000Res. 6:260","journal-title":"F1000Res."},{"key":"4700_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrd.2016.85","volume":"15","author":"K Smietana","year":"2016","unstructured":"Smietana K, Siatkowski M, Moller M (2016) Trends in clinical success rates. Nat Rev Drug Discov 15:379\u2013380","journal-title":"Nat Rev Drug Discov"},{"key":"4700_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","volume":"15","author":"RK Harrison","year":"2016","unstructured":"Harrison RK (2016) Phase II and phase III failures: 2013\u20132015. Nat Rev Drug Discov 15:817\u2013818","journal-title":"Nat Rev Drug Discov"},{"issue":"10015","key":"4700_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(16)00049-0","volume":"387","author":"R Barnett","year":"2016","unstructured":"Barnett R (2016) Parkinson\u2019s disease. Lancet 387(10015):217","journal-title":"Lancet"},{"key":"4700_CR21","doi-asserted-by":"publisher","first-page":"e1008489","DOI":"10.1371\/journal.pgen.1008489","volume":"15","author":"EA King","year":"2019","unstructured":"King EA, Davis JW, Degner JF (2019) Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet 15:e1008489","journal-title":"PLoS Genet"},{"key":"4700_CR22","doi-asserted-by":"publisher","first-page":"18911","DOI":"10.1038\/s41598-019-54849-w","volume":"9","author":"AD Hingorani","year":"2019","unstructured":"Hingorani AD, Kuan V, Finan C, Kruger FA, Gaulton A, Chopade S et al (2019) Improving the odds of drug development success through human genomics: modelling study. Sci Rep 9:18911","journal-title":"Sci Rep"},{"key":"4700_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y et al (2015) The support of human genetic evidence for approved drug indications. Nat Genet 47:856\u2013860","journal-title":"Nat Genet"},{"key":"4700_CR24","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1073\/pnas.0903103106","volume":"106","author":"LA Hindorff","year":"2009","unstructured":"Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS et al (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106:9362\u20139367","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4700_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091\u20131102","journal-title":"Lancet Neurol"},{"key":"4700_CR26","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1212\/NXG.0000000000000348","volume":"5","author":"H Iwaki","year":"2019","unstructured":"Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grodem J, Corvol JC et al (2019) Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts. Neurol Genet 5:e348","journal-title":"Neurol Genet"},{"key":"4700_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrom L et al (2019) Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord 34:866\u2013875","journal-title":"Mov Disord"},{"key":"4700_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","volume":"14","author":"MV Holmes","year":"2017","unstructured":"Holmes MV, Ala-Korpela M, Smith GD (2017) Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 14:577\u2013590","journal-title":"Nat Rev Cardiol"},{"key":"4700_CR29","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","volume":"366","author":"A Hingorani","year":"2005","unstructured":"Hingorani A, Humphries S (2005) Nature\u2019s randomised trials. Lancet 366:1906\u20131908","journal-title":"Lancet"},{"key":"4700_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S (2003) \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1\u201322","journal-title":"Int J Epidemiol"},{"key":"4700_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(86)92972-7","volume":"1","author":"MB Katan","year":"1986","unstructured":"Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1:507\u2013508","journal-title":"Lancet"},{"key":"4700_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang P, Yao L, Luo M, Zhou W, Jin X, Xu Z et al (2021) Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson\u2019s disease. Cell Discov 7:52","journal-title":"Cell Discov"},{"key":"4700_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53:1300\u20131310","journal-title":"Nat Genet"},{"issue":"2","key":"4700_CR34","first-page":"e557","volume":"7","author":"I Alfradique-Dunham","year":"2021","unstructured":"Alfradique-Dunham I, Al-Ouran R, Van Coelln R, Blauwendraat C, Hill E, Luo L et al (2021) Genome-wide association study meta-analysis for Parkinson disease motor subtypes. Neurol: Genet 7(2):e557","journal-title":"Neurol: Genet"},{"key":"4700_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N et al (2018) Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19:477","journal-title":"BMC Genomics"},{"key":"4700_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH et al (2021) Inference and analysis of cell-cell communication using Cell Chat. Nat Commun 12:1088","journal-title":"Nat Commun"},{"key":"4700_CR37","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36:1783\u20131802","journal-title":"Stat Med"},{"key":"4700_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512\u2013525","journal-title":"Int J Epidemiol"},{"key":"4700_CR39","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey SG (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13:e1007081","journal-title":"PLoS Genet"},{"key":"4700_CR40","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10:e1004383","journal-title":"PLoS Genet"},{"key":"4700_CR41","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J et al (2019) PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations. Bioinformatics 35:4851\u20134853","journal-title":"Bioinformatics"},{"key":"4700_CR42","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1212\/WNL.0000000000004516","volume":"89","author":"R Shamir","year":"2017","unstructured":"Shamir R, Klein C, Amar D, Vollstedt E-J, Bonin M, Usenovic M et al (2017) Analysis of blood-based gene expression in idiopathic Parkinson disease. Neurology 89:1676\u20131683","journal-title":"Neurology"},{"key":"4700_CR43","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"4700_CR44","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"4700_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuint.2016.12.002","volume":"102","author":"YY Jung","year":"2017","unstructured":"Jung YY, Katila N, Neupane S, Shadfar S, Ojha U, Bhurtel S et al (2017) Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32\u03b2 transgenic mice. Neurochem Int 102:79\u201388","journal-title":"Neurochem Int"},{"key":"4700_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","volume":"109","author":"KR Aass","year":"2021","unstructured":"Aass KR, Kastnes MH, Standal T (2021) Molecular interactions and functions of IL-32. J Leukoc Biol 109:143\u2013159","journal-title":"J Leukoc Biol"},{"key":"4700_CR47","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22:131\u2013142","journal-title":"Immunity"},{"key":"4700_CR48","doi-asserted-by":"publisher","first-page":"41629","DOI":"10.1038\/srep41629","volume":"7","author":"MSMA Damen","year":"2017","unstructured":"Damen MSMA, Agca R, Holewijn S, de Graaf J, Dos Santos JC, van Riel PL et al (2017) IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep. 7:41629","journal-title":"Sci Rep."},{"key":"4700_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00432-017-2431-5","volume":"143","author":"S Bhat","year":"2017","unstructured":"Bhat S, Gardi N, Hake S, Kotian N, Sawant S, Kannan S et al (2017) Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients. J Cancer Res Clin Oncol 143:1745\u20131756","journal-title":"J Cancer Res Clin Oncol"},{"key":"4700_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/15412555.2016.1145201","volume":"13","author":"E Gasiuniene","year":"2016","unstructured":"Gasiuniene E, Lavinskiene S, Sakalauskas R, Sitkauskiene B (2016) Levels of IL-32 in serum, induced sputum supernatant, and bronchial lavage fluid of patients with chronic obstructive pulmonary disease. COPD 13:569\u2013575","journal-title":"COPD"},{"key":"4700_CR51","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13277-015-3829-9","volume":"37","author":"K Erturk","year":"2016","unstructured":"Erturk K, Tastekin D, Serilmez M, Bilgin E, Bozbey HU, Vatansever S (2016) Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer. Tumour Biol 37:405\u2013412","journal-title":"Tumour Biol"},{"key":"4700_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12957-015-0552-3","volume":"13","author":"Y Yang","year":"2015","unstructured":"Yang Y, Wang Z, Zhou Y, Wang X, Xiang J, Chen Z (2015) Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis. World J Surg Oncol 13:146","journal-title":"World J Surg Oncol"},{"key":"4700_CR53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14:329\u2013342","journal-title":"Nat Rev Immunol"},{"key":"4700_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","volume":"180","author":"C Sorrentino","year":"2009","unstructured":"Sorrentino C, Di Carlo E (2009) Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 180:769\u2013779","journal-title":"Am J Respir Crit Care Med"},{"key":"4700_CR55","doi-asserted-by":"publisher","first-page":"110158","DOI":"10.1016\/j.mehy.2020.110158","volume":"144","author":"L Gong","year":"2020","unstructured":"Gong L, Dong C, Cai Q, Ouyang W (2020) Interleukin 32: a novel player in perioperative neurocognitive disorders. Med Hypotheses 144:110158","journal-title":"Med Hypotheses"},{"key":"4700_CR56","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.4049\/jimmunol.174.9.5243","volume":"174","author":"A Deng","year":"2005","unstructured":"Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM (2005) Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 174:5243\u20135248","journal-title":"J Immunol"},{"key":"4700_CR57","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1111\/jocd.14792","volume":"21","author":"HN Khalid","year":"2022","unstructured":"Khalid HN, Elghobashy YAE, Elsayed AN (2022) GNLY gene polymorphism: a potential role in understanding psoriasis pathogenesis. J Cosmet Dermatol 21:4805\u20134809","journal-title":"J Cosmet Dermatol"},{"key":"4700_CR58","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.7150\/thno.48052","volume":"10","author":"L Hao","year":"2020","unstructured":"Hao L, Ma J, Shi C, Lin X, Zhang Y, Jo-Lewis BN et al (2020) Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery. Theranostics 10:10046\u201310056","journal-title":"Theranostics"},{"key":"4700_CR59","doi-asserted-by":"publisher","first-page":"971528","DOI":"10.3389\/fnagi.2022.971528","volume":"14","author":"D Li","year":"2022","unstructured":"Li D, Liang J, Guo W, Zhang Y, Wu X, Zhang W (2022) Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson\u2019s disease. Front Aging Neurosci 14:971528","journal-title":"Front Aging Neurosci"},{"key":"4700_CR60","first-page":"27","volume":"71","author":"A Sekovani\u0107","year":"2020","unstructured":"Sekovani\u0107 A, Jurasovi\u0107 J, Piasek M (2020) Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans. Arch Ind Hyg Toxicol 71:27\u201347","journal-title":"Arch Ind Hyg Toxicol"},{"key":"4700_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","volume":"12","author":"GJ Michael","year":"2011","unstructured":"Michael GJ, Esmailzadeh S, Moran LB, Christian L, Pearce RK, Graeber MB (2011) Up-regulation of metallothionein gene expression in parkinsonian astrocytes. Neurogenetics 12:295\u2013305","journal-title":"Neurogenetics"},{"key":"4700_CR62","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/ng.221","volume":"40","author":"A Franke","year":"2008","unstructured":"Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G et al (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40:1319\u20131323","journal-title":"Nat Genet"},{"key":"4700_CR63","first-page":"3189","volume":"41","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Wei W, Wu Z, Wang J, Ding X, Sheng Y et al (2019) ARPC2 promotes breast cancer proliferation and metastasis. Oncol Rep 41:3189\u20133200","journal-title":"Oncol Rep"},{"key":"4700_CR64","doi-asserted-by":"publisher","first-page":"5432818","DOI":"10.1155\/2017\/5432818","volume":"2017","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu Y, Yu CJ, Dai F, Xiong J, Li HJ et al (2017) Role of ARPC2 in human gastric cancer. Mediators Inflamm 2017:5432818","journal-title":"Mediators Inflamm"},{"key":"4700_CR65","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41418-020-00704-9","volume":"28","author":"Y Fang","year":"2021","unstructured":"Fang Y, Jiang Q, Li S, Zhu H, Xu R, Song N et al (2021) Opposing functions of beta-arrestin 1 and 2 in Parkinson\u2019s disease via microglia inflammation and Nprl3. Cell Death Differ 28:1822\u20131836","journal-title":"Cell Death Differ"},{"key":"4700_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2019.00124","volume":"10","author":"RA Bond","year":"2019","unstructured":"Bond RA, Lucero Garcia-Rojas EY, Hegde A, Walker JKL (2019) Therapeutic potential of targeting ss-arrestin. Front Pharmacol 10:124","journal-title":"Front Pharmacol"},{"key":"4700_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pharmthera.2008.11.005","volume":"121","author":"CL Schmid","year":"2009","unstructured":"Schmid CL, Bohn LM (2009) Physiological and pharmacological implications of beta-arrestin regulation. Pharmacol Ther 121:285\u2013293","journal-title":"Pharmacol Ther"},{"key":"4700_CR68","doi-asserted-by":"publisher","first-page":"E2517","DOI":"10.1073\/pnas.1502740112","volume":"112","author":"NM Urs","year":"2015","unstructured":"Urs NM, Bido S, Peterson SM, Daigle TL, Bass CE, Gainetdinov RR et al (2015) Targeting beta-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 112:E2517-2526","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4700_CR69","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/cdd.2013.152","volume":"21","author":"X Feng","year":"2014","unstructured":"Feng X, Wu CY, Burton FH, Loh HH, Wei LN (2014) Beta-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia. Cell Death Differ 21:397\u2013406","journal-title":"Cell Death Differ"},{"key":"4700_CR70","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","volume":"25","author":"J Zhu","year":"2018","unstructured":"Zhu J, Hu Z, Han X, Wang D, Jiang Q, Ding J et al (2018) Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of beta-arrestin2 and NLRP3. Cell Death Differ 25:2037\u20132049","journal-title":"Cell Death Differ"},{"key":"4700_CR71","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.nbd.2022.105744","volume":"170","author":"M Bartl","year":"2022","unstructured":"Bartl M, Xylaki M, Bahr M, Weber S, Trenkwalder C, Mollenhauer B (2022) Evidence for immune system alterations in peripheral biological fluids in Parkinson\u2019s disease. Neurobiol Dis 170:105744","journal-title":"Neurobiol Dis"},{"key":"4700_CR72","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-021-02287-9","volume":"18","author":"A Kouli","year":"2021","unstructured":"Kouli A, Jensen M, Papastavrou V, Scott KM, Kolenda C, Parker C et al (2021) T lymphocyte senescence is attenuated in Parkinson\u2019s disease. J Neuroinflammation 18:228","journal-title":"J Neuroinflammation"},{"key":"4700_CR73","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74:995\u20131002","journal-title":"Neurology"},{"key":"4700_CR74","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ et al (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol 58:963\u2013967","journal-title":"Ann Neurol"},{"key":"4700_CR75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","volume":"247","author":"T Preglej","year":"2022","unstructured":"Preglej T, Ellmeier W (2022) CD4(+) Cytotoxic T cells - phenotype, function and transcriptional networks controlling their differentiation pathways. Immunol Lett 247:27\u201342","journal-title":"Immunol Lett"},{"key":"4700_CR76","doi-asserted-by":"publisher","first-page":"867189","DOI":"10.3389\/fimmu.2022.867189","volume":"13","author":"M Cenerenti","year":"2022","unstructured":"Cenerenti M, Saillard M, Romero P, Jandus C (2022) The era of cytotoxic CD4 T cells. Front Immunol 13:867189","journal-title":"Front Immunol"},{"key":"4700_CR77","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1073\/pnas.1907883116","volume":"116","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H et al (2019) Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc Natl Acad Sci U S A 116:24242\u201324251","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4700_CR78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11357-010-9200-6","volume":"33","author":"R Alonso-Arias","year":"2011","unstructured":"Alonso-Arias R, Moro-Garcia MA, Lopez-Vazquez A, Rodrigo L, Baltar J, Garcia FM et al (2011) NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) 33:591\u2013605","journal-title":"Age (Dordr)"},{"key":"4700_CR79","doi-asserted-by":"publisher","first-page":"113315","DOI":"10.1016\/j.expneurol.2020.113315","volume":"330","author":"A Haque","year":"2020","unstructured":"Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D et al (2020) Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson\u2019s disease. Exp Neurol 330:113315","journal-title":"Exp Neurol"},{"key":"4700_CR80","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.compbiomed.2023.106801","volume":"158","author":"S Yan","year":"2023","unstructured":"Yan S, Si Y, Zhou W, Cheng R, Wang P, Wang D et al (2023) Single-cell transcriptomics reveals the interaction between peripheral CD4(+) CTLs and mesencephalic endothelial cells mediated by IFNG in Parkinson\u2019s disease. Comput Biol Med 158:106801","journal-title":"Comput Biol Med"},{"key":"4700_CR81","doi-asserted-by":"publisher","first-page":"12975","DOI":"10.1074\/jbc.RA118.004267","volume":"293","author":"S Mehra","year":"2018","unstructured":"Mehra S, Ghosh D, Kumar R, Mondal M, Gadhe LG, Das S et al (2018) Glycosaminoglycans have variable effects on \u03b1-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils. J Biol Chem 293:12975\u201312991","journal-title":"J Biol Chem"},{"key":"4700_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00983-w","volume":"8","author":"L Sheng","year":"2020","unstructured":"Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P et al (2020) Erythrocytic \u03b1-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson\u2019s disease pathogenesis. Acta Neuropathol Commun 8:1\u201322","journal-title":"Acta Neuropathol Commun"},{"key":"4700_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Y-T Sui","year":"2014","unstructured":"Sui Y-T, Bullock KM, Erickson MA, Zhang J, Banks WA (2014) Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier. Peptides 62:197\u2013202","journal-title":"Peptides"},{"key":"4700_CR84","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2021.06.004","volume":"89","author":"CD McKnight","year":"2021","unstructured":"McKnight CD, Trujillo P, Lopez AM, Petersen K, Considine C, Lin Y-C et al (2021) Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease. Parkinsonism Relat Disord 89:98\u2013104","journal-title":"Parkinsonism Relat Disord"},{"key":"4700_CR85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","volume":"106","author":"J Huang","year":"2022","unstructured":"Huang J, Ding J, Wang X, Gu C, He Y, Li Y et al (2022) Transfer of neuron-derived \u03b1-synuclein to astrocytes induces neuroinflammation and blood\u2013brain barrier damage after methamphetamine exposure: involving the regulation of nuclear receptor-associated protein 1. Brain Behav Immun 106:247\u2013261","journal-title":"Brain Behav Immun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:02:39Z","timestamp":1747195359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4700"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04700-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies used in the analysis received ethical approval from their respective institutional review boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}